Role of Antiretroviral Therapy in the Prevention of HIV Transmission Myron S. Cohen, MD, Chief of the Division of Infectious Diseases at the University of North Carolina School of Medicine at Chapel ...

Generic versions of a groundbreaking injectable HIV-prevention drug should be available for $40 a year in more than 100 ...

The Food and Drug Administration has approved Yeztugo, a revolutionary HIV prevention injection that represents the most significant advancement in HIV prevention strategies in more than four decades.

WASHINGTON (AP) — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it's unclear how many ...

Lenacapavir has the potential to end the HIV epidemic, researchers say. The Trump administration says backing this kind of ...

Discover how lenacapavir, a revolutionary HIV prevention tool, will be available for just $40 annually to 120 low- and middle ...

A groundbreaking injectable drug, lenacapavir, offers renewed hope in the fight against HIV. Set to be available in 2027 in ...

Advances in HIV medication, its window of detection and its transmission risk within the last decade have led to an updated ...

Lenacapavir is a long-acting injectable antiretroviral drug developed by Gilead Sciences. It is administered just twice a ...

When diagnosed with HIV, the timing of treatment initiation can significantly impact long-term health outcomes and quality of life. Medical experts increasingly advocate for immediate treatment ...

Roy M. Anderson, FRS, from Imperial College, University of London, England, discussed the use of mathematical models to shed light on aspects of the HIV epidemic, including predicting the effects of ...

The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global rollout that could protect millions – although it’s unclear how many in the U.S. and ...